Changes the Asset Allocation Committee Has Made
Executive Summary
- As the coronavirus disrupts lives and trade worldwide, coordinated monetary and fiscal policies are essential to mitigate the stresses to global economies.
- Recession is likely in several developed European and Asian countries by mid‑2020, and the probability is increasing that the U.S. economy will contract.
- We have been incrementally adding to equities as valuations are beginning to price in a substantial decline in economic growth and corporate earnings.
Q. What is your view on the current environment?
We believe that global policymakers are now more coordinated in their responses to stem the impacts of the coronavirus on the global economy. The U.S. Federal Reserve and other major central banks have sharply lowered interest rates while pledging a return to aggressive quantitative easing measures. The U.S. and several other countries are also implementing fiscal stimulus measures to support their economies. In our view, the aggressive measures taken by policymakers are important in providing stability and liquidity to the volatile markets.
How the coronavirus outbreak will ultimately impact economic growth and corporate earnings will largely be driven by the duration of the crisis. In the short term, it is likely that several developed market economies in Europe and Asia will dip into recession in the first half of 2020, and the U.S. could likely see contraction in the coming quarters.
Q. What actions are you taking in this environment?
Disciplined Rebalancing
As risk assets have sold off aggressively, more defensive assets, such as U.S. Treasury bonds, have become increasingly expensive. In this environment, we continue to focus on rebalancing our portfolios with discipline. Our exposure to core investment‑grade bonds and U.S. long‑term Treasuries, which have performed strongly, has provided a natural funding source for rebalancing into equities, which have declined.
Measured Additions
While it is difficult to call a bottom to the current sell‑off in risk assets, we are confident that markets will normalize once the impacts of the coronavirus pass. Given our long‑term investment horizon, we are adding incrementally to average into positions where we find attractive valuations.
We have selectively added across equities as valuations are beginning to price in a substantial contraction in economic growth and a decline in corporate earnings. We have funded the additions from core investment‑grade bonds that have become increasingly expensive and riskier as their durations have extended.
Within U.S. equities, although we remain overweight to growth stocks, we have moderated our underweight to value stocks, which have significantly lagged growth stocks amid the sell‑off. While value‑oriented equities are more cyclical, their relative valuations versus growth stocks have reached extreme levels and could be poised for a more pronounced rebound once volatility mitigates.
Q. What key market indicators are you watching?
We are actively monitoring the crisis at a macro level as well as its impacts on market liquidity and the risks to corporate credit and fundamentals. While the market sell‑off is not the result of a financial crisis, an extended period of uncertainty could exacerbate financial and liquidity stresses. However, we believe that—given their aggressive action—central banks are committed to mitigating these stresses.
We are also focused on how countries across the globe are responding to contain the spread of the virus. While monetary and fiscal measures may support the potential economic impacts in the weeks and months ahead, investors are keenly focused to see evidence that the spread of the coronavirus is moving past its peak. Data suggesting a slowdown in new infections will be a key catalyst in stabilizing markets.
Q. How were you prepared going into the current sell‑off?
Our multi‑asset investment approach emphasizes broad diversification, the importance of active management, a long‑term horizon, and an understanding of the risks at each level of the portfolio.
Diversification: While the pronounced sell‑off in risk assets has been broad‑based, the drawdown to our diversified multi‑asset portfolios has been buffered by allocations to core bonds, as yields have reached record‑low levels amid the flight to quality assets. Notably, the strategic allocations to long‑term U.S. Treasury bonds as a ballast to equities has been a significant contributor to returns in the current environment, helping to offset equity market drawdowns and provide liquidity.
Active Management: As the crisis unfolds, it is ever more important for us to understand the impacts at not only the asset class level, but also at the individual company level as well. Our global research capabilities give us a deep understanding of each portfolio holding.
Indiscriminate and broad‑based market sell-offs can provide opportunity for active investors to benefit by buying quality companies at distressed valuations. Our ability to rebalance our portfolios from expensive core bonds into stocks—that have cheapened significantly—gives us capital to deploy where we are finding quality companies at deeply discounted prices.
Long‑Term Horizon: Our tactical asset allocation approach looks out over a 6‑ to 18‑month time horizon, with an emphasis on relative valuations. Our longer investment horizon provides us with the patience and flexibility to average into positions when markets sell off aggressively. We believe that as the impacts of the coronavirus ultimately begin to abate, volatility will subside, and markets will refocus on fundamentals.
Risk‑Aware Approach: We emphasize risk management at each level of our multi‑asset investment process. Our portfolios are designed with an emphasis on understanding the potential risks versus returns; as such, we seek to build portfolios that can weather a range of market environments. We achieve this by including diversifying elements that have lower correlations with each other and can mitigate overall portfolio risk.
Important Information
This material is being furnished for general informational and/or marketing purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, nor is it intended to serve as the primary basis for an investment decision. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.
The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.
Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources’ accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date written and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.
The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request. It is not intended for distribution to retail investors in any jurisdiction.
Australia—Issued in Australia by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 50, Governor Phillip Tower, 1 Farrer Place, Suite 50B, Sydney, NSW 2000, Australia. For Wholesale Clients only.
Canada—Issued in Canada by T. Rowe Price (Canada), Inc. T. Rowe Price (Canada), Inc.’s investment management services are only available to Accredited Investors as defined under National Instrument 45-106. T. Rowe Price (Canada), Inc. enters into written delegation agreements with affiliates to provide investment management services.
DIFC—Issued in the Dubai International Financial Centre by T. Rowe Price International Ltd. This material is communicated on behalf of T. Rowe Price International Ltd. by its representative office which is regulated by the Dubai Financial Services Authority. For Professional Clients only.
EEA ex-UK—Unless indicated otherwise this material is issued and approved by T. Rowe Price (Luxembourg) Management S.à r.l. 35 Boulevard du Prince Henri L-1724 Luxembourg which is authorised and regulated by the Luxembourg Commission de Surveillance du Secteur Financier. For Professional Clients only.
Hong Kong—Issued by T. Rowe Price Hong Kong Limited, 6/F, Chater House, 8 Connaught Road Central, Hong Kong. T. Rowe Price Hong Kong Limited is licensed and regulated by the Securities & Futures Commission. For Professional Investors only.
New Zealand—Issued in New Zealand by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 50, Governor Phillip Tower, 1 Farrer Place, Suite 50B, Sydney, NSW 2000, Australia. No Interests are offered to the public. Accordingly, the Interests may not, directly or indirectly, be offered, sold or delivered in New Zealand, nor may any offering document or advertisement in relation to any offer of the Interests be distributed in New Zealand, other than in circumstances where there is no contravention of the Financial Markets Conduct Act 2013.
Singapore—Issued in Singapore by T. Rowe Price Singapore Private Ltd., No. 501 Orchard Rd, #10-02 Wheelock Place, Singapore 238880. T. Rowe Price Singapore Private Ltd. is licensed and regulated by the Monetary Authority of Singapore. For Institutional and Accredited Investors only.
Switzerland—Issued in Switzerland by T. Rowe Price (Switzerland) GmbH, Talstrasse 65, 6th Floor, 8001 Zurich, Switzerland. For Qualified Investors only.
UK—This material is issued and approved by T. Rowe Price International Ltd, 60 Queen Victoria Street, London, EC4N 4TZ which is authorised and regulated by the UK Financial Conduct Authority. For Professional Clients only.
USA—Issued in the USA by T. Rowe Price Associates, Inc., 100 East Pratt Street, Baltimore, MD, 21202, which is regulated by the U.S. Securities and Exchange Commission. For Institutional Investors only.
© 2020 T. Rowe Price. All rights reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, and the bighorn sheep design are, collectively and/or apart, trademarks or registered trademarks of T. Rowe Price Group, Inc.
ID0003099 (03/2020)
202003‑1123677